Scientists divided over restricted use approval for Covaxin
The Hindu
While the 3,000 sites across India readies to vaccinate 300 million high-risk individuals beginning with healthcare workers from January 16, scientists and doctors are divided over restricted use approval granted to the Hyderabad-based Bharat Biotech’s Covaxin, a COVID-19 vaccine.
In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the Indian regulator are safe. The Health Ministry released a statement made by four-dozen scientists and doctors in India who “collectively assure” the safety of both the vaccines.
More Related News

Thomas Jefferson and Abraham Lincoln are two of the greatest presidents that the U.S. has seen. You probably know that already. But did you know that Jefferson made what is considered the first contribution to American vertebrate paleontology? Or that Lincoln is the only U.S. president to receive a patent? What’s more, both their contributions have March 10 in common… 52 years apart. A.S.Ganesh hands you the details…